SCHEMBL7335607

SCHEMBL7335607

CCCCCn1nc(C(=O)CC)nc1Cc1ccc(-c2cccnc2-c2nnn[nH]2)cc1

nearest known ligand 0.42

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 2/20 0.41
AGTR2 P50052 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7342374 0.98 AGTR1 (0.43) AGTR1
SCHEMBL7340900 0.94 AGTR1 (0.40) AGTR1AGTR2
SCHEMBL7342817 0.94 AGTR1 (0.40) AGTR1
SCHEMBL7344953 0.94 AGTR1 (0.37) AGTR1
SCHEMBL7339393 0.94 AGTR1 (0.39) AGTR1AGTR2
SCHEMBL7344490 0.93 AGTR1 (0.41) AGTR1
SCHEMBL7335510 0.92 AGTR1 (0.42) AGTR1
SCHEMBL7335235 0.92 AGTR1 (0.42) AGTR1
SCHEMBL7342525 0.91 AGTR1 (0.41) AGTR1
SCHEMBL7332887 0.91 AGTR1 (0.43) AGTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6090828-A ARTHERIOSCLEROSIS REITZ DAVID B (US) 2000-07-18 US disclosed
US-5451593-A Method of using 5-arylheteroarylalkyl-1,3,5-trisubstituted-1,2,4-triazole compounds for treatment of a glaucoma disorder G. D. SEARLE & CO. (US) 1995-09-19 US disclosed
US-5451591-A Method of using 5-arylheteroarylalkyl-1,3 5-trisubstituted-1,24-triazole compounds for treatment of circulatory disorders G. D. SEARLE & CO. (US) 1995-09-19 US disclosed
US-5274155-A Intramolecular arbuzov process for the preparation of intermediates useful in the preparation of phosphorus containing HMG-COA reductase inhibitors E. R. SQUIBB & SONS, INC. (US) 1993-12-28 US disclosed
US-5196537-A Angiotensin/II/ antagonists; hypotensive agents G. D. SEARLE & CO. (US) 1993-03-23 US disclosed
EP-0508665-A2 Use of ACE inhibitors for lowering serum cholesterol E.R. SQUIBB & SONS, INC. (US) 1992-10-14 EP disclosed
WO-1992016523-A1 5-ARYLHETEROARYLALKYL-1,3,5-TRISUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS G.D. SEARLE & CO. (US) 1992-10-01 WO disclosed
EP-0504888-A1 5-Arylheteroarylalkyl-1,3,5-trisubstituted-1,2,4-triazole compounds for treatment of circulatory disorders G.D. Searle & Co. (US) 1992-09-23 EP disclosed